DK Life Science Co., Ltd. (KOSDAQ:303810)

Market Cap	86.20B -42.5%
Revenue (ttm)	128.38B -3.7%
Net Income	8.71B +129.2%
EPS	272.08 +134.2%
Shares Out	31.98M
PE Ratio	9.91
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,702
Open	2,695.00
Previous Close	2,695.00
Day's Range	2,665.00 - 2,880.00
52-Week Range	2,615.00 - 5,350.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DK Life Science

DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea and internationally. It offers active pharmaceutical ingredients (API), injections, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instruments. The company also offers catheters, MRI, CT scanner, ultrasound, mobile CT scanner, and X-ray equipment, as well as mammography image analysis assistance software. DK Life Science Co., Ltd. was founded in 2017 and is based in Seoul, South Korea.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2017
• Employees: 100
• Stock Exchange: KOSDAQ
• Ticker Symbol: 303810

Financial Performance

In 2025, DK Life Science's revenue was 130.34 billion, a decrease of -1.12% compared to the previous year's 131.82 billion. Earnings were 8.66 billion, an increase of 285.71%.